IMVIF — Imv Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $7.67m
- $0.33m
Annual cashflow statement for Imv, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Net Income/Starting Line | -16.9 | -20.6 | -23.4 | -36.6 | -38 |
Depreciation | |||||
Non-Cash Items | 2.45 | 1.02 | 0.744 | 2.89 | 1.85 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.969 | -1.36 | -1.26 | 1.11 | 1.74 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -13.3 | -20.6 | -23.5 | -32 | -33.4 |
Capital Expenditures | -1.69 | -0.359 | -0.331 | -1.4 | -1.07 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.011 | 0 | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -1.68 | -0.359 | -0.331 | -1.4 | -1.07 |
Financing Cash Flow Items | -0.367 | -1.88 | -1.6 | -2.27 | -1.43 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.9 | 20.3 | 49 | 35.8 | 17.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.011 | -0.625 | 25.5 | 2.35 | -17.4 |